Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
CAR T cell immunotherapy shows promise for patients with kidney cancer
Chimeric antigen receptor (CAR) T cell therapy is a type [...]
Real world data on the use of cabozantinib plus immunotherapy in the second line
A recent study looked at the use of a combination [...]
Immunotherapy improves survival in kidney cancer patients with brain metastases
A recent real world study has found that giving immunotherapy [...]
NICE approves cabozantinib plus nivolumab for advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) has approved the [...]
PRISM study highlights possibility of reducing dose of immunotherapy
The CheckMate-214 clinical trial was the first study to show [...]
World-class radiotherapy in the UK
Led by the All Party Parliamentary Group for Radiotherapy, the [...]
Summary of kidney cancer highlights from ASCO GU 2024
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO [...]
Cancer treatment could identify patients most likely to respond to cancer drugs
Scientists from Cancer Research UK and Memorial Sloan Kettering Cancer [...]
